CAMPATH-1 antigen — Drug Target

All drugs that target CAMPATH-1 antigen — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

CD52-directed Cytolytic Antibody [EPC]

Marketed (2)

• Campath · National Heart, Lung, and Blood Institute (NHLBI) · Oncology
• Campath · Sanofi · CD52-directed Cytolytic Antibody [EPC] · Oncology
  Campath works by binding to a specific protein on the surface of immune cells, marking them for destruction.